Brook, J. D. et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68, 799–808 (1992).

Article  PubMed  Google Scholar 

Mahadevan, M. et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255, 1253–1255 (1992).

Article  PubMed  CAS  Google Scholar 

Liao, Q., Zhang, Y., He, J. & Huang, K. Global prevalence of myotonic dystrophy: an updated systematic review and meta-analysis. Neuroepidemiology 56, 163–173 (2022).

Article  PubMed  Google Scholar 

Johnson, N. E. et al. Population-based prevalence of myotonic dystrophy type 1 using genetic analysis of statewide blood screening program. Neurology 96, e1045–e1053 (2021).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Harper, P. S. Myotonic Dystrophy 3rd edn, 37 (WB Saunders, 2001).

Zapata-Aldana, E., Ceballos-Saenz, D., Hicks, R. & Campbell, C. Prenatal, neonatal, and early childhood features in congenital myotonic dystrophy. J. Neuromuscul. Dis. 5, 331–340 (2018).

Article  PubMed  Google Scholar 

Johnson, N. E. et al. Parent-reported multi-national study of the impact of congenital and childhood onset myotonic dystrophy. Dev. Med. Child. Neurol. 58, 698–705 (2016).

Article  PubMed  Google Scholar 

Lagrue, E. et al. A large multicenter study of pediatric myotonic dystrophy type 1 for evidence-based management. Neurology 92, e852–e865 (2019).

Article  PubMed  Google Scholar 

Johnson, N. E. et al. Disease burden and functional outcomes in congenital myotonic dystrophy: a cross-sectional study. Neurology 87, 160–167 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Campbell, C., Levin, S., Siu, V. M., Venance, S. & Jacob, P. Congenital myotonic dystrophy: Canadian population-based surveillance study. J. Pediatr. 163, 120–125 e121–e123 (2013).

Article  PubMed  Google Scholar 

Maagdenberg, S. J. M. et al. Impact of gastrointestinal and urological symptoms in children with myotonic dystrophy type 1. Neuromuscul. Disord. 35, 1–7 (2024).

Article  PubMed  Google Scholar 

Quigg, K. H. et al. 12-month progression of motor and functional outcomes in congenital myotonic dystrophy. Muscle Nerve 63, 384–391 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Reardon, W., Newcombe, R., Fenton, I., Sibert, J. & Harper, P. S. The natural history of congenital myotonic dystrophy: mortality and long term clinical aspects. Arch. Dis. Child. 68, 177–181 (1993).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Aden, P., Skarbo, A. B., Wallace, S., Orstavik, K. & Rasmussen, M. Cognitive function, behaviour and quality of life in children with myotonic dystrophy type 1 in south-eastern Norway. Eur. J. Paediatr. Neurol. 45, 1–6 (2023).

Article  PubMed  Google Scholar 

Douniol, M. et al. Psychiatric and cognitive phenotype of childhood myotonic dystrophy type 1. Dev. Med. Child. Neurol. 54, 905–911 (2012).

Article  PubMed  Google Scholar 

Logigian, E. L. et al. Quantitative analysis of the “warm-up” phenomenon in myotonic dystrophy type 1. Muscle Nerve 32, 35–42 (2005).

Article  PubMed  CAS  Google Scholar 

Okkersen, K. et al. The cognitive profile of myotonic dystrophy type 1: a systematic review and meta-analysis. Cortex 95, 143–155 (2017).

Article  PubMed  Google Scholar 

Okkersen, K. et al. Brain imaging in myotonic dystrophy type 1: a systematic review. Neurology 89, 960–969 (2017).

Article  PubMed  Google Scholar 

de Die-Smulders, C. E. et al. Age and causes of death in adult-onset myotonic dystrophy. Brain 121, 1557–1563 (1998).

Article  PubMed  Google Scholar 

Mathieu, J., Allard, P., Potvin, L. & Prévost, C. & Bégin, P. a 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 52, 1658–1662 (1999).

Article  PubMed  CAS  Google Scholar 

Johnson, N. E., Abbott, D. & Cannon-Albright, L. A. Relative risks for comorbidities associated with myotonic dystrophy: a population-based analysis. Muscle Nerve 52, 659–661 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Wahbi, K. et al. Development and validation of a new scoring system to predict survival in patients with myotonic dystrophy type 1. JAMA Neurol. 75, 573–581 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Gadalla, S. M. et al. Cancer risk among patients with myotonic muscular dystrophy. JAMA 306, 2480–2486 (2011).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Emparanza, J. I. et al. Cancer phenotype in myotonic dystrophy patients: results from a meta-analysis. Muscle Nerve 58, 517–522 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Gadalla, S. M. et al. Quantifying cancer absolute risk and cancer mortality in the presence of competing events after a myotonic dystrophy diagnosis. PLoS ONE8, e79851 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Joosten, I. B. T. et al. Myotonic dystrophy type 1: a comparison between the adult- and late-onset subtype. Muscle Nerve 67, 130–137 (2023).

Article  PubMed  CAS  Google Scholar 

Harley, H. G. et al. Localisation of the myotonic dystrophy locus to 19q13.2–19q13.3 and its relationship to twelve polymorphic loci on 19q. Hum. Genet. 87, 73–80 (1991).

Article  PubMed  CAS  Google Scholar 

Harley, H. G. et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 355, 545–546 (1992).

Article  PubMed  CAS  Google Scholar 

Fu, Y. H. et al. Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science 260, 235–238 (1993).

Article  PubMed  CAS  Google Scholar 

Jansen, G. et al. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat. Genet. 13, 316–324 (1996).

Article  PubMed  CAS  Google Scholar 

Berul, C. I. et al. DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. J. Clin. Invest. 103, R1–R7 (1999).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Frisch, R. et al. Effect of triplet repeat expansion on chromatin structure and expression of DMPK and neighboring genes, SIX5 and DMWD, in myotonic dystrophy. Mol. Genet. Metab. 74, 281–291 (2001).

Article  PubMed  CAS  Google Scholar 

Inukai, A. et al. Reduced expression of DMAHP/SIX5 gene in myotonic dystrophy muscle. Muscle Nerve 23, 1421–1426 (2000).

Article  PubMed  CAS  Google Scholar 

Yanovsky-Dagan, S. et al. Uncovering the role of hypermethylation by CTG expansion in myotonic dystrophy type 1 using mutant human embryonic stem cells. Stem Cell Rep. 5, 221–231 (2015).

Article  CAS